Home > > > > Report Detail

Stem Cell Therapy Market by Type (Allogeneic, Autologous), Cell Source (Adipose Tissue, Bone Marrow, Placenta/Umbilical Cord), Therapeutic Application (Musculoskeletal, Wounds, Surgeries, Inflammatory, Autoimmune, Cardiovascular) - Global Forecast to 2028

Publisher Name :
Date: 12-Dec-2023
No. of pages: 203
Inquire Before Buying

“Increasing clinical trials for stem cell based-therapies is driving the overall growth of the stem cell therapy market.”

The global stem cell therapy market is projected to reach USD 615 million by 2028 from USD 286 million in 2023, at a CAGR of 16.5% during the forecast period.Key market players are focusing on developing new stem cell therapies for various disease conditions this is one of the major factor is likely to impact the market growth in coming years. The increasing number of clinical trials has largely in past few years coupled with rise in FDA approvals for stem cell therapy is anticipated to give momentum to the market growth.

“The allogeneic stem cell segment accounted dominant share in 2022”

The stem cell therapy market is segmented into allogeneic and autologous. Allogeneic segment accounted for the dominant share in 2022. In allogeneic stem cell therapy, one cell source can produce numerous doses, thus making allogeneic therapy economically viable and less time-consuming, these are some of the major elements responsible for the doninat share of the segment. Presently, more than ten approved commercialized allogeneic stem cell therapies are available globally.

“Bone Marrow-derived MSCs segment is anticipated to grow at significant CAGR”

Based on the cell source the global stem cell therapy market is segmented into adipose tissue-derived MSCs, bone marrow-derived MSCs, placenta/umbilical cord-derived MSCs, and other cell sources. In 2022, the adipose tissue-derived MSCs segment gained dominant share in the stem cell therapy market. Bone marrow-derived mesenchymal stem cells most preferred type for are stem cell therapies. Easy availability of Bone marrow MSCs and less time required for in-vitro processing are some of the major factorslikely to give momentum to the use of bone marrow derived MSCs uplifting the segmental growth.

“Asia Pacific region is likely to grow at a faster pace.”

The stem cell therapy market is segmented into North America, Europe, Asia Pacific and Rest of the world. Asia Pacific region is anticipated to grow at a significant CAGR during the forecast period. Rising approvals from the government for stem cell therapy in South Korea. Furthermore, industrial collabrations in the region for stem cell therapy development is further likely to give pace for the market growth in the region. For instance, Reyon Pharmaceutical and Therabest entered into a joint development agreement for NK cell therapy for treating solid cancer. Under this agreement, the two companies will jointly develop iPSC (induced pluripotent stem cell)-derived NK cell therapy ‘TB-100’ for solid cancer indications.

The primary interviews conducted for this report can be categorized as follows:


  • By Respondent: Supply Side- 80%, and Demand Side - 20%

  • By Designation (Supply Side): Managers - 45%, CXOs & Directors - 30%, Executives- 25%

  • By Region: North America -40%, Asia-Pacific -20%, Europe -30%,  ROW-10%


List of Companies Profiled in the Report:


  • Smith+Nephew (UK)

  • MEDIPOST Co. Ltd. (South Korea)

  • Anterogen Co. Ltd. (South Korea)

  • CORESTEM (South Korea)

  • Pharmicell Co. Ltd. (South Korea)

  • NuVasive Inc. (US)

  • RTI Surgical (US)

  • AlloSource (US)

  • JCR Pharmaceuticals Co. Ltd. (Japan)

  • Takeda Pharmaceutical Company Limited (Japan)

  • Holostem Terapie Avanzate Srl (Italy)

  • Orthofix (US)

  • Regrow Biosciences Pvt Ltd. (India)

  • STEMPEUTICS RESEARCH PVT LTD. (India)

  • Athersys (US)

  • Mesoblast Ltd (Australia)

  • Biorestorative Therapies Inc. (US)

  • Pluristem Inc. (Israel)

  • Brainstorm Cell Limited. (US)

  • ViaCyte Inc. (US)

  • Gamida Cell (US)

  • Kangstem Biotech (South Korea)

  • Hope Biosciences (US)

  • Cellular Biomedicine Group (US)

  • Personalized Stem Cells (US)


Research Coverage:

This report provides a detailed picture of the stem cell therapy market. It aims to estimate the size and future growth potential of the market across different segments, such as such as the type, therapeutic applications, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall stem cell therapy market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:


  • Analysis of key drivers (Increased funding for stem cell research, rise in collabrations and partnerships is likley to uplift the market growth,  Increasing clinical trials for stem cell based-therapies), restraints ( Ethical concerns related to embryonic stem cells, high cost of cell-based research), opportunities (The emergence of iPSCs as an alternative to ESCs, growing demand for stem cell and gene therapy) and challenges (Technical limitations) are influencing the growth of stem cell therapy market.

  • Product Development/Innovation: Detailed insights on newly launched products of the stem cell therapy market.

  • Market Development: Comprehensive information about lucrative markets – the report analyses the stem cell therapy market across varied regions.

  • Market Diversification: Exhaustive information about new services, untapped geographies, recent developments, and investments in the stem cell therapy market.

  • Pipeline Analysis: Detailed information on stem cell therapy under phase 3 clinical trials.

  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players include Smith+Nephew (UK), MEDIPOST Co. Ltd. (South Korea), Anterogen Co. Ltd. (South Korea), CORESTEM (South Korea) and among others in the stem cell therapy market.  

Stem Cell Therapy Market by Type (Allogeneic, Autologous), Cell Source (Adipose Tissue, Bone Marrow, Placenta/Umbilical Cord), Therapeutic Application (Musculoskeletal, Wounds, Surgeries, Inflammatory, Autoimmune, Cardiovascular) - Global Forecast to 2028

Table Of Contents

1 Introduction 28
1.1 Study Objectives 28
1.2 Market Definition 28
1.3 Inclusions & Exclusions 29
1.4 Market Scope 29
1.4.1 Markets Covered 29
1.4.2 Years Considered 30
1.5 Currency 30
1.6 Research Limitations 30
1.7 Stakeholders 31
1.8 Summary Of Changes 31
1.9 Recession Impact 32

2 Research Methodology 33
2.1 Research Data 33
Figure 1 Research Design 33
2.1.1 Secondary Data 34
2.1.2 Primary Data 35
Figure 2 Breakdown Of Primaries: Stem Cell Therapy Market 35
2.2 Market Size Estimation 36
Figure 3 Market Size Estimation For Supply-Side Analysis, 2022 36
Figure 4 Market Size Estimation: Revenue Share Analysis, 2022 37
Figure 5 Smith+Nephew: Revenue Share Analysis, 2022 37
2.2.1 Primary Insights 38
Figure 6 Validation From Primary Experts 38
2.2.2 Segment Assessment Methodology: Stem Cell Therapy Market 39
Figure 7 Market Size Estimation Methodology: Top-Down Approach 39
Figure 8 Cagr Projections: Stem Cell Therapy Market 40
Figure 9 Growth Analysis Of Drivers, Restraints, Challenges, And Opportunities 40
2.3 Market Breakdown And Data Triangulation 41
Figure 10 Data Triangulation Methodology 41
2.4 Study Assumptions 42
2.5 Risk Analysis 42
2.6 Impact Of Recession On Stem Cell Therapy Market 43
Table 1 Global Inflation Rate Projection, 2024–2028 (% Growth) 43
Table 2 Us Health Expenditure, 2019–2022 (Usd Million) 43
Table 3 Us Health Expenditure, 2023–2027 (Usd Million) 44

3 Executive Summary 45
Figure 11 Stem Cell Therapy Market, By Type, 2023 Vs. 2028 (Usd Million) 45
Figure 12 Stem Cell Therapy Market, By Cell Source, 2023 Vs. 2028 (Usd Million) 46
Figure 13 Stem Cell Therapy Market, By Therapeutic Application, 2023 Vs. 2028 (Usd Million) 46
Figure 14 Regional Snapshot Of Stem Cell Therapy Market 47

4 Premium Insights 49
4.1 Stem Cell Therapy Market Overview 49
Figure 15 Increasing Investments And Funding For Stem Cell Research To Drive Market 49
4.2 North America: Stem Cell Therapy Market, By Type And Country, 2022 50
Figure 16 Allogeneic Stem Cell Therapy Accounted For Largest Market Share In 2022 50
4.3 Stem Cell Therapy Market: Geographical Growth Opportunities 51
Figure 17 South Korea To Register Highest Growth Rate During Forecast Period 51

5 Market Overview 52
5.1 Introduction 52
5.2 Market Dynamics 52
Figure 18 Stem Cell Therapy Market: Drivers, Restraints,
Opportunities, And Challenges 52
5.2.1 Drivers 53
5.2.1.1 Increased Funding For Stem Cell Research 53
Table 4 Funding For Stem Cell Research By Indian Council Of Medical Research, 2019–2022 (Usd) 53
Table 5 Funding For Cell-Based Research By National Institutes Of Health, 2018–2023 (Usd Million) 53
5.2.1.2 Rising Number Of Collaborations Among Healthcare Institutes 54
5.2.1.3 Increasing Number Of Clinical Trials For Stem Cell-Based Therapies 55
Figure 19 Number Of Clinical Trials, 2015–2022 55
5.2.2 Restraints 56
5.2.2.1 Ethical Concerns Related To Use Of Embryonic Stem Cells 56
5.2.2.2 High Cost Of Cell-Based Research And Stem Cell Therapy 56
5.2.3 Opportunities 57
5.2.3.1 Increased Availability Of Alternatives To Embryonic Stem Cells 57
5.2.3.2 Growing Demand For Cell And Gene Therapies 58
5.2.4 Challenges 58
5.2.4.1 Technological Limitations 58
5.3 Technology Analysis 59
Table 6 Comparison Between Stem Cell Therapies And Gene Therapies 59

5.4 Disruptions And Trends Impacting Customer’s Business 60
Figure 20 Revenue Shift And New Pocket For Key Players In Stem Cell Therapy Market 60
5.5 Value Chain Analysis 60
Figure 21 Stem Cell Therapy Market: Value Chain Analysis 61
5.6 Ecosystem Market Map 61
Figure 22 Stem Cell Therapy Market: Ecosystem Market Map 61
5.7 Supply Chain Analysis 62
Figure 23 Stem Cell Therapy Market: Supply Chain Analysis 62
Table 7 Supply Chain Analysis: Role Of Commercial-Scale/Key Manufacturers 63
Table 8 Supply Chain Analysis: Pipeline/Emerging Manufacturers 63
5.8 Porter’s Five Forces Analysis 64
5.8.1 Threat Of New Entrants 64
5.8.2 Threat Of Substitutes 64
5.8.3 Bargaining Power Of Suppliers 64
5.8.4 Bargaining Power Of Buyers 65
5.8.5 Intensity Of Competition Rivalry 65
5.9 Regulatory Analysis 65
5.9.1 Regulatory Landscape 65
5.9.1.1 North America 65
Table 9 North America: Regulatory Landscape For Stem Cell Therapies 65
5.9.1.2 Europe 68
Table 10 Europe: Regulatory Landscape For Stem Cell Therapies 68
5.9.1.3 Asia Pacific 69
Table 11 Asia Pacific: Regulatory Landscape For Stem Cell Therapies 69
5.9.1.4 Rest Of The World 71
Table 12 Rest Of The World: Regulatory Landscape For Stem Cell Therapies 71
5.9.2 Regulatory Bodies, Government Agencies, And Other Organizations 72
Table 13 North America: Regulatory Bodies, Government Agencies, And Other Organizations 72
Table 14 Europe: Regulatory Bodies, Government Agencies, And Other Organizations 72
Table 15 Asia Pacific: Regulatory Bodies, Government Agencies, And Other Organizations 74
Table 16 Rest Of The World: Regulatory Bodies, Government Agencies, And Other Organizations 75
5.10 Pricing Analysis 75
5.10.1 Pricing Analysis 75
Table 17 Average Selling Price Of Drug Therapies Offered By Key Players In Stem Cell Therapy Market 75
5.10.2 Average Selling Price Trend For Stem Cell Therapies 76

5.11 Patent Analysis 77
Figure 24 Stem Cell Therapy: Patent Analysis, 2013–2023 77
5.12 Key Conferences & Events 78
Table 18 List Of Key Conferences & Events, 2023–2024 78
5.13 Pipeline Analysis 78
5.14 Key Stakeholders & Buying Criteria 81
Figure 25 Key Stakeholders 81
5.14.1 Key Buying Criteria 82
Figure 26 Key Buying Criteria For End Users 82

6 Stem Cell Therapy Market, By Cell Source 83
6.1 Introduction 84
Table 19 Stem Cell Therapy Market, By Cell Source, 2021–2028 (Usd Million) 84
6.2 Adipose Tissue-Derived Mesenchymal Stem Cells 84
6.2.1 Ease Of Isolation And Harvesting To Drive Growth 84
Table 20 Adipose Tissue-Derived Mesenchymal Stem Cells Market, By Region, 2021–2028 (Usd Million) 85
Table 21 North America: Adipose Tissue-Derived Mesenchymal Stem Cells Market, By Country, 2021–2028 (Usd Million) 85
Table 22 Europe: Adipose Tissue-Derived Mesenchymal Stem Cells Market, By Country, 2021–2028 (Usd Million) 86
Table 23 Asia Pacific: Adipose Tissue-Derived Mesenchymal Stem Cells Market, By Country, 2021–2028 (Usd Million) 86
6.3 Bone Marrow-Derived Mesenchymal Stem Cells 86
6.3.1 High Prevalence Of Metabolic Disorders To Support Market Growth 86
Table 24 Bone Marrow-Derived Mesenchymal Stem Cells Market, By Region, 2021–2028 (Usd Million) 87
Table 25 North America: Bone Marrow-Derived Mesenchymal Stem Cells Market, By Country, 2021–2028 (Usd Million) 87
Table 26 Europe: Bone Marrow-Derived Mesenchymal Stem Cells Market, By Country, 2021–2028 (Usd Million) 88
Table 27 Asia Pacific: Bone Marrow-Derived Mesenchymal Stem Cells Market, By Country, 2021–2028 (Usd Million) 88
6.4 Placenta/Umbilical Cord-Derived Mesenchymal Stem Cells 88
6.4.1 Low Chances Of Rejection From Immune System To Propel Growth 88
Table 28 Placenta/Umbilical Cord-Derived Mesenchymal Stem Cells Market, By Region, 2021–2028 (Usd Million) 89
Table 29 North America: Placenta/Umbilical Cord-Derived Mesenchymal Stem Cells Market, By Country, 2021–2028 (Usd Million) 89
Table 30 Europe: Placenta/Umbilical Cord-Derived Mesenchymal Stem Cells Market, By Country, 2021–2028 (Usd Million) 90
Table 31 Asia Pacific: Placenta/Umbilical Cord-Derived Mesenchymal Stem Cells Market, By Country, 2021–2028 (Usd Million) 90

6.5 Other Cell Sources 90
Table 32 Stem Cell Therapy Market For Other Cell Sources, By Region, 2021–2028 (Usd Million) 91
Table 33 North America: Stem Cell Therapy Market For Other Cell Sources, By Country, 2021–2028 (Usd Million) 91
Table 34 Europe: Stem Cell Therapy Market For Other Cell Sources, By Country, 2021–2028 (Usd Million) 91
Table 35 Asia Pacific: Stem Cell Therapy Market For Other Cell Sources, By Country, 2021–2028 (Usd Million) 92

7 Stem Cell Therapy Market, By Type 93
7.1 Introduction 94
Table 36 Stem Cell Therapy Market, By Type, 2021–2028 (Usd Million) 94
7.2 Allogeneic Stem Cell Therapy 94
7.2.1 Economically Viable And Less Time-Consuming—Key Factors Driving Market Growth 94
Table 37 Allogeneic Stem Cell Therapy Market, By Region, 2021–2028 (Usd Million) 95
Table 38 North America: Allogeneic Stem Cell Therapy Market, By Country, 2021–2028 (Usd Million) 95
Table 39 Europe: Allogeneic Stem Cell Therapy Market, By Country, 2021–2028 (Usd Million) 95
Table 40 Asia Pacific: Allogeneic Stem Cell Therapy Market, By Country, 2021–2028 (Usd Million) 96
7.3 Autologous Stem Cell Therapy 96
7.3.1 Low Risk Of Post-Treatment Complications To Drive Growth 96
Table 41 Autologous Stem Cell Therapy Market, By Region, 2021–2028 (Usd Million) 97
Table 42 North America: Autologous Stem Cell Therapy Market, By Country, 2021–2028 (Usd Million) 97
Table 43 Europe: Autologous Stem Cell Therapy Market, By Country, 2021–2028 (Usd Million) 97
Table 44 Asia Pacific: Autologous Stem Cell Therapy Market, By Country, 2021–2028 (Usd Million) 98

8 Stem Cell Therapy Market, By Therapeutic Application 99
8.1 Introduction 100
Table 45 Stem Cell Therapy Market, By Therapeutic Application, 2021–2028 (Usd Million) 100
8.2 Musculoskeletal Disorders 100
8.2.1 Increasing Cases Of Osteoarthritis To Drive Market 100
Table 46 Stem Cell Therapy Market For Musculoskeletal Disorders, By Region, 2021–2028 (Usd Million) 101
Table 47 North America: Stem Cell Therapy Market For Musculoskeletal Disorders, By Country, 2021–2028 (Usd Million) 101
Table 48 Europe: Stem Cell Therapy Market For Musculoskeletal Disorders, By Country, 2021–2028 (Usd Million) 101
Table 49 Asia Pacific: Stem Cell Therapy Market For Musculoskeletal Disorders, By Country, 2021–2028 (Usd Million) 102
8.3 Wounds & Surgeries 102
8.3.1 Increasing Benefits Of Allogeneic-Based Therapies To Support Market Growth 102
Table 50 Stem Cell Therapy Market For Wounds & Surgeries, By Region, 2021–2028 (Usd Million) 103
Table 51 North America: Stem Cell Therapy Market For Wounds & Surgeries, By Country, 2021–2028 (Usd Million) 103
Table 52 Europe: Stem Cell Therapy Market For Wounds & Surgeries, By Country, 2021–2028 (Usd Million) 103
Table 53 Asia Pacific: Stem Cell Therapy Market For Wounds & Surgeries, By Country, 2021–2028 (Usd Million) 104
8.4 Inflammatory & Autoimmune Diseases 104
8.4.1 Increasing Clinical Trials To Support Market Growth 104
Table 54 Stem Cell Therapy Market For Inflammatory & Autoimmune Diseases, By Region, 2021–2028 (Usd Million) 104
Table 55 North America: Stem Cell Therapy Market For Inflammatory & Autoimmune Diseases, By Country, 2021–2028 (Usd Million) 105
Table 56 Europe: Stem Cell Therapy Market For Inflammatory & Autoimmune Diseases, By Country, 2021–2028 (Usd Million) 105
Table 57 Asia Pacific: Stem Cell Therapy Market For Inflammatory & Autoimmune Diseases, By Country, 2021–2028 (Usd Million) 105
8.5 Cardiovascular Diseases 106
8.5.1 Increasing Public & Private Funding For Cvd Research To Drive Market 106
Table 58 Stem Cell Therapy Market For Cardiovascular Diseases, By Region, 2021–2028 (Usd Million) 106
Table 59 North America: Stem Cell Therapy Market For Cardiovascular Diseases, By Country, 2021–2028 (Usd Million) 106
Table 60 Europe: Stem Cell Therapy Market For Cardiovascular Diseases, By Country, 2021–2028 (Usd Million) 107
Table 61 Asia Pacific: Stem Cell Therapy Market For Cardiovascular Diseases, By Country, 2021–2028 (Usd Million) 107
8.6 Neurological Disorders 107
8.6.1 Rising Prevalence Of Neurological Disorders To Propel Market 107
Table 62 Stem Cell Therapy Market For Neurological Disorders, By Region, 2021–2028 (Usd Million) 108
Table 63 North America: Stem Cell Therapy Market For Neurological Disorders, By Country, 2021–2028 (Usd Million) 108
Table 64 Europe: Stem Cell Therapy Market For Neurological Disorders, By Country, 2021–2028 (Usd Million) 108
Table 65 Asia Pacific: Stem Cell Therapy Market For Neurological Disorders, By Country, 2021–2028 (Usd Million) 109
8.7 Other Therapeutic Applications 109
Table 66 Stem Cell Therapy Market For Other Therapeutic Applications, By Region, 2021–2028 (Usd Million) 109
Table 67 North America: Stem Cell Therapy Market For Other Therapeutic Applications, By Country, 2021–2028 (Usd Million) 110
Table 68 Europe: Stem Cell Therapy Market For Other Therapeutic Applications, By Country, 2021–2028 (Usd Million) 110
Table 69 Asia Pacific: Stem Cell Therapy Market For Other Therapeutic Applications, By Country, 2021–2028 (Usd Million) 110

9 Stem Cell Therapy Market, By Region 111
9.1 Introduction 112
Table 70 Stem Cell Therapy Market, By Region, 2021–2028 (Usd Million) 112
9.2 North America 113
Figure 27 North America: Stem Cell Therapy Market Snapshot 113
Table 71 North America: Stem Cell Therapy Market, By Country, 2021–2028 (Usd Million) 114
Table 72 North America: Stem Cell Therapy Market, By Cell Source, 2021–2028 (Usd Million) 114
Table 73 North America: Stem Cell Therapy Market, By Type, 2021–2028 (Usd Million) 114
Table 74 North America: Stem Cell Therapy Market, By Therapeutic Application, 2021–2028 (Usd Million) 115
9.2.1 Us 115
9.2.1.1 Increase In Stem Cell Therapy Approvals To Drive Market 115
Table 75 Us: Stem Cell Therapy Market, By Cell Source, 2021–2028 (Usd Million) 116
Table 76 Us: Stem Cell Therapy Market, By Type, 2021–2028 (Usd Million) 116
Table 77 Us: Stem Cell Therapy Market, By Therapeutic Application, 2021–2028 (Usd Million) 116
9.2.2 Canada 117
9.2.2.1 Increase In Research Activities Targeted Toward Stem Cell Therapies To Propel Market 117
Table 78 Canada: Stem Cell Therapy Market, By Cell Source, 2021–2028 (Usd Million) 117
Table 79 Canada: Stem Cell Therapy Market, By Type, 2021–2028 (Usd Million) 118
Table 80 Canada: Stem Cell Therapy Market, By Therapeutic Application, 2021–2028 (Usd Million) 118
9.2.3 Recession Impact On North American Stem Cell Therapy Market 118
9.3 Europe 119
Table 81 Europe: Stem Cell Therapy Market, By Country, 2021–2028 (Usd Million) 119
Table 82 Europe: Stem Cell Therapy Market, By Cell Source, 2021–2028 (Usd Million) 119
Table 83 Europe: Stem Cell Therapy Market, By Type, 2021–2028 (Usd Million) 120
Table 84 Europe: Stem Cell Therapy Market, By Therapeutic Application, 2021–2028 (Usd Million) 120
9.3.1 Germany 120
9.3.1.1 Increasing Incidence Of Sports-Related Injuries To Drive Market 120
Table 85 Germany: Stem Cell Therapy Market, By Cell Source, 2021–2028 (Usd Million) 121
Table 86 Germany: Stem Cell Therapy Market, By Type, 2021–2028 (Usd Million) 121
Table 87 Germany: Stem Cell Therapy Market, By Therapeutic Application, 2021–2028 (Usd Million) 121
9.3.2 Uk 122
9.3.2.1 Rising Adoption Of Cell-Based Therapies To Propel Market 122
Table 88 Uk: Stem Cell Therapy Market, By Cell Source, 2021–2028 (Usd Million) 122
Table 89 Uk: Stem Cell Therapy Market, By Type, 2021–2028 (Usd Million) 122
Table 90 Uk: Stem Cell Therapy Market, By Therapeutic Application, 2021–2028 (Usd Million) 123
9.3.3 France 123
9.3.3.1 Rising R&D Expenditure For Stem Cell Therapy To Support Market Growth 123
Table 91 France: Stem Cell Therapy Market, By Cell Source, 2021–2028 (Usd Million) 124
Table 92 France: Stem Cell Therapy Market, By Type, 2021–2028 (Usd Million) 124
Table 93 France: Stem Cell Therapy Market, By Therapeutic Application, 2021–2028 (Usd Million) 124
9.3.4 Italy 125
9.3.4.1 Rising Prevalence Of Neurological And Cardiovascular Disorders To Drive Market 125
Table 94 Italy: Stem Cell Therapy Market, By Cell Source, 2021–2028 (Usd Million) 125
Table 95 Italy: Stem Cell Therapy Market, By Type, 2021–2028 (Usd Million) 125
Table 96 Italy: Stem Cell Therapy Market, By Therapeutic Application, 2021–2028 (Usd Million) 126
9.3.5 Spain 126
9.3.5.1 Rising Prevalence Of Cvd To Propel Market 126
Table 97 Spain: Stem Cell Therapy Market, By Cell Source, 2021–2028 (Usd Million) 127
Table 98 Spain: Stem Cell Therapy Market, By Type, 2021–2028 (Usd Million) 127
Table 99 Spain: Stem Cell Therapy Market, By Therapeutic Application, 2021–2028 (Usd Million) 127
9.3.6 Rest Of Europe 128
Table 100 Rest Of Europe: Stem Cell Therapy Market, By Cell Source, 2021–2028 (Usd Million) 128
Table 101 Rest Of Europe: Stem Cell Therapy Market, By Type, 2021–2028 (Usd Million) 128
Table 102 Rest Of Europe: Stem Cell Therapy Market, By Therapeutic Application, 2021–2028 (Usd Million) 129
9.3.7 Recession Impact On European Stem Cell Therapy Market 129

9.4 Asia Pacific 130
Figure 28 Asia Pacific: Stem Cell Therapy Market Snapshot 130
Table 103 Asia Pacific: Stem Cell Therapy Market, By Country, 2021–2028 (Usd Million) 131
Table 104 Asia Pacific: Stem Cell Therapy Market, By Cell Source, 2021–2028 (Usd Million) 131
Table 105 Asia Pacific: Stem Cell Therapy Market, By Type, 2021–2028 (Usd Million) 131
Table 106 Asia Pacific: Stem Cell Therapy Market, By Therapeutic Application, 2021–2028 (Usd Million) 132
9.4.1 Japan 132
9.4.1.1 Growing Geriatric Population And Faster Regulatory Approval Process To Augment Market Growth 132
Table 107 Japan: Stem Cell Therapy Market, By Cell Source, 2021–2028 (Usd Million) 133
Table 108 Japan: Stem Cell Therapy Market, By Type, 2021–2028 (Usd Million) 133
Table 109 Japan: Stem Cell Therapy Market, By Therapeutic Application, 2021–2028 (Usd Million) 133
9.4.2 South Korea 134
9.4.2.1 Presence Of Major Players To Support Market Growth In South Korea 134
Table 110 South Korea: Stem Cell Therapy Market, By Cell Source, 2021–2028 (Usd Million) 134
Table 111 South Korea: Stem Cell Therapy Market, By Type, 2021–2028 (Usd Million) 134
Table 112 South Korea: Stem Cell Therapy Market, By Therapeutic Application, 2021–2028 (Usd Million) 135
9.4.3 India 135
9.4.3.1 Rising Incidence Of Neurodegenerative Disorders And Diabetes To Drive Market 135
Table 113 India: Stem Cell Therapy Market, By Cell Source, 2021–2028 (Usd Million) 136
Table 114 India: Stem Cell Therapy Market, By Type, 2021–2028 (Usd Million) 136
Table 115 India: Stem Cell Therapy Market, By Therapeutic Application, 2021–2028 (Usd Million) 136
9.4.4 China 137
9.4.4.1 Increasing Investments In Stem Cell Research To Drive Market 137
Table 116 China: Stem Cell Therapy Market, By Cell Source, 2021–2028 (Usd Million) 137
Table 117 China: Stem Cell Therapy Market, By Type, 2021–2028 (Usd Million) 137
Table 118 China: Stem Cell Therapy Market, By Therapeutic Application, 2021–2028 (Usd Million) 138
9.4.5 Rest Of Asia Pacific 138
Table 119 Rest Of Asia Pacific: Stem Cell Therapy Market, By Cell Source, 2021–2028 (Usd Million) 138
Table 120 Rest Of Asia Pacific: Stem Cell Therapy Market, By Type, 2021–2028 (Usd Million) 139
Table 121 Rest Of Asia Pacific: Stem Cell Therapy Market, By Therapeutic Application, 2021–2028 (Usd Million) 139
9.4.6 Recession Impact On Asia Pacific Stem Cell Therapy Market 139
9.5 Rest Of The World 140
Table 122 Rest Of The World: Stem Cell Therapy Market, By Cell Source, 2021–2028 (Usd Million) 140
Table 123 Rest Of The World: Stem Cell Therapy Market, By Type, 2021–2028 (Usd Million) 140
Table 124 Rest Of The World: Stem Cell Therapy Market, By Therapeutic Application, 2021–2028 (Usd Million) 141
9.5.1 Recession Impact On Rest Of The World Stem Cell Therapy Market 141

10 Competitive Landscape 142
10.1 Introduction 142
10.2 Strategies Adopted By Key Players 143
Figure 29 Stem Cell Therapy Market: Strategies Adopted By Key Players 143
10.3 Revenue Share Analysis 144
Figure 30 Revenue Analysis Of Top Players, 2020−2022 (Usd Million) 144
10.4 Market Share Analysis 144
Figure 31 Stem Cell Therapy Market: Market Share Analysis, By Key Player, 2022 145
Table 125 Stem Cell Therapy Market: Intensity Of Competitive Rivalry 145
10.5 Company Evaluation Matrix 146
Figure 32 Stem Cell Therapy Market: Company Evaluation Matrix For Key Players, 2022 147
10.5.1 Stars 147
10.5.2 Emerging Leaders 147
10.5.3 Pervasive Players 148
10.5.4 Participants 148
10.6 Competitive Benchmarking Of Key Players 148
Table 126 Therapeutic Application Footprint Of Companies 148
10.7 Regional Footprint Of Top 15 Companies 149
Table 127 Regional Footprint Of Companies 149
10.8 Startup/Sme Evaluation Matrix 150
Figure 33 Stem Cell Therapy Market: Startup/Sme Evaluation Matrix, 2022 150
10.8.1 Progressive Companies 151
10.8.2 Responsive Companies 151
10.8.3 Dynamic Companies 151
10.8.4 Starting Blocks 151
10.9 Competitive Benchmarking Of Startups/Smes 152
Table 128 Stem Cell Therapy Market: Product Footprint Analysis Of Startups/Smes 152
Table 129 Stem Cell Therapy Market: Competitive Benchmarking Of Startups/Smes 154
10.10 Competitive Scenarios And Trends 155
10.10.1 Product Approvals 155
Table 130 Stem Cell Therapy Market: Product Approvals, January 2020–October 2023 155
10.10.2 Deals 155
Table 131 Stem Cell Therapy Market: Deals, January 2020–October 2023 155
10.10.3 Other Developments 156
Table 132 Stem Cell Therapy Market: Other Developments, January 2020–October 2023 156

11 Company Profiles 157
(Business Overview, Products Offered, Recent Developments, And Mnm View (Key Strengths/Right To Win, Strategic Choices Made, And Weaknesses And Competitive Threats))*
11.1 Key Players 157
11.1.1 Smith+Nephew 157
Table 133 Smith+Nephew: Business Overview 157
Figure 34 Smith+Nephew: Company Snapshot (2022) 158
11.1.2 Medipost 160
Table 134 Medipost: Business Overview 160
Figure 35 Medipost: Company Snapshot (2021) 160
11.1.3 Jcr Pharmaceuticals Co., Ltd. 164
Table 135 Jcr Pharmaceuticals Co., Ltd.: Business Overview 164
Figure 36 Jcr Pharmaceuticals Co., Ltd: Company Snapshot (2022) 165
11.1.4 Takeda Pharmaceutical Company Limited 167
Table 136 Takeda Pharmaceutical Company Limited: Business Overview 167
Figure 37 Takeda Pharmaceutical Company Limited: Company Snapshot (2022) 168
11.1.5 Anterogen Co., Ltd. 170
Table 137 Anterogen Co., Ltd.: Business Overview 170
11.1.6 Corestem, Inc. 171
Table 138 Corestem Inc.: Business Overview 171
Figure 38 Corestem Inc.: Company Snapshot (2021) 171
11.1.7 Pharmicell Co., Ltd 173
Table 139 Pharmicell Co., Ltd: Business Overview 173
11.1.8 Nuvasive, Inc. 175
Table 140 Nuvasive, Inc.: Business Overview 175
Figure 39 Nuvasive, Inc.: Company Snapshot (2022) 176
11.1.9 Rti Surgical 177
Table 141 Rti Surgical: Business Overview 177
11.1.10 Allosource 178
Table 142 Allosource: Business Overview 178
11.1.11 Holostem Terapie Avanzate Srl 179
Table 143 Holostem Terapie Avanzate Srl: Business Overview 179
11.1.12 Orthofix Medical Inc. 180
Table 144 Orthofix Medical Inc.: Business Overview 180
Figure 40 Orthofix Medical Inc.: Company Snapshot (2022) 181
11.1.13 Stempeutics Research Pvt Ltd. 182
Table 145 Stempeutics Research Pvt Ltd.: Business Overview 182
11.1.14 Regrow Biosciences Pvt Ltd. 184
Table 146 Regrow Biosciences Pvt Ltd.: Business Overview 184
11.2 Other Players 185
11.2.1 Athersys, Inc. 185
Table 147 Athersys, Inc.: Business Overview 185
11.2.2 Mesoblast Ltd. 186
Table 148 Mesoblast Ltd.: Business Overview 186
11.2.3 Biorestorative Therapies, Inc. 188
Table 149 Biorestorative Therapies, Inc.: Business Overview 188
11.2.4 Pluristem Therapeutics Inc. 189
Table 150 Pluristem Therapeutics Inc.: Business Overview 189
11.2.5 Brainstorm Cell Limited 190
Table 151 Brainstorm Cell Limited: Business Overview 190
11.2.6 Gamida Cell 191
Table 152 Gamida Cell: Business Overview 191
11.2.7 Viacyte, Inc. 192
Table 153 Viacyte, Inc.: Business Overview 192
11.2.8 Kangstem Biotech Co., Ltd. 193
Table 154 Kangstem Biotech Co., Ltd.: Business Overview 193
11.2.9 Hope Biosciences 194
Table 155 Hope Biosciences: Business Overview 194
11.2.10 Cellular Biomedicine Group 195
Table 156 Cellular Biomedicine Group: Business Overview 195
11.2.11 Personalized Stem Cells 196
Table 157 Personalized Stem Cells: Business Overview 196
*Details On Business Overview, Products Offered, Recent Developments, And Mnm View (Key Strengths/Right To Win, Strategic Choices Made, And Weaknesses And Competitive Threats) Might Not Be Captured In Case Of Unlisted Companies.

12 Appendix 197
12.1 Discussion Guide 197
12.2 Knowledgestore: Marketsandmarkets’ Subscription Portal 200
12.3 Customization Options 201
12.4 Related Reports 202
12.5 Author Details 203

  • Global Animal Stem Cell Therapy Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 89
    Animal stem cell therapy is a usage of animal's stem cell to treat a disease or disorder. The ability of stem cell is to divide and differentiate into a cell with specialized function useful for repairing body tissues damaged by injury or disease. The animal stem cell therapy process involves three steps which include collection of stem cell sample from animals and preparing The sample to concentrate The stem cells. Finally, The therapy includes transferring The stem cells into The injured site ......
  • Global Mesenchymal Stem Cells Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 104
    According to our LPI (LP Information) latest study, the global Mesenchymal Stem Cells market size was valued at US$ 202.6 million in 2023. With growing demand in downstream market, the Mesenchymal Stem Cells is forecast to a readjusted size of US$ 278.8 million by 2030 with a CAGR of 4.7% during review period. The research report highlights the growth potential of the global Mesenchymal Stem Cells market. Mesenchymal Stem Cells are expected to show stable growth in the future market. How......
  • Global Stem Cells Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 151
    According to our LPI (LP Information) latest study, the global Stem Cells market size was valued at US$ 2693.1 million in 2023. With growing demand in downstream market, the Stem Cells is forecast to a readjusted size of US$ 5700.6 million by 2030 with a CAGR of 11.3% during review period. The research report highlights the growth potential of the global Stem Cells market. Stem Cells are expected to show stable growth in the future market. However, product differentiation, reducing costs......
  • Global Stem Cell Therapy Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 88
    According to our LPI (LP Information) latest study, the global Stem Cell Therapy market size was valued at US$ 469.1 million in 2023. With growing demand in downstream market, the Stem Cell Therapy is forecast to a readjusted size of US$ 1724 million by 2030 with a CAGR of 20.4% during review period. The research report highlights the growth potential of the global Stem Cell Therapy market. Stem Cell Therapy are expected to show stable growth in the future market. However, product differ......
  • Global Animal Stem Cell Therapy Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 114
    According to our LPI (LP Information) latest study, the global Animal Stem Cell Therapy market size was valued at US$ 199.3 million in 2023. With growing demand in downstream market, the Animal Stem Cell Therapy is forecast to a readjusted size of US$ 476.2 million by 2030 with a CAGR of 13.2% during review period. The research report highlights the growth potential of the global Animal Stem Cell Therapy market. Animal Stem Cell Therapy are expected to show stable growth in the future ma......
  • Global Stem Cell Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 112
    Market Overview of Global Stem Cell market: According to our latest research, the global Stem Cell market looks promising in the next 5 years. As of 2022, the global Stem Cell market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Stem cells are cells that can differentiate into other types of cells, and can also divide in self-renewal to produce more of the same type of stem cells. ......
  • Global Animal Stem Cell Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 112
    According to our (Global Info Research) latest study, the global Animal Stem Cell Therapy market size was valued at USD 209.7 million in 2023 and is forecast to a readjusted size of USD 469.9 million by 2030 with a CAGR of 12.2% during review period. Animal stem cell therapy is a usage of animal's stem cell to treat a disease or disorder. The ability of stem cell is to divide and differentiate into a cell with specialized function useful for repairing body tissues damaged by injury or di......
  • Global Hematopoietic Stem Cells Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 114
    Market Overview of Global Hematopoietic Stem Cells market: According to our latest research, the global Hematopoietic Stem Cells market looks promising in the next 5 years. As of 2022, the global Hematopoietic Stem Cells market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global......
  • Global Adipose Stem Cells (ASCS) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 122
    Market Overview of Global Adipose Stem Cells (ASCS) market: According to our latest research, the global Adipose Stem Cells (ASCS) market looks promising in the next 5 years. As of 2022, the global Adipose Stem Cells (ASCS) market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the glo......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs